Abstract: Antagonists of glucagon-like peptide 2, have been identified. Their effects on the growth of gastrointestinal tissue are described. Its formulation as a pharmaceutical, and its therapeutic and related uses in treating bowel tissue, are described. Also described are methods of identifying antagonists of glucagon-like peptide 2.
Type:
Grant
Filed:
July 19, 1996
Date of Patent:
November 30, 1999
Assignee:
1149336 Ontario Inc.
Inventors:
Daniel J. Drucker, Anna E. Crivici, Martin Sumner-Smith